Ellis Christopher 4
4 · Vaccitech plc · Filed Aug 19, 2022
Insider Transaction Report
Form 4
Vaccitech plcVACC
Ellis Christopher
Chief Operating Officer
Transactions
- Sale
Ordinary Shares
2022-08-17$4.77/sh−649$3,093→ 75 total - Exercise/Conversion
Share Option (Right to Buy)
2022-08-17−649→ 42,781 totalExercise: $0.00Exp: 2028-02-16→ Ordinary Shares (649 underlying) - Exercise/Conversion
Share Option (Right to Buy)
2022-08-18−2,175→ 40,606 totalExercise: $0.00Exp: 2028-02-16→ Ordinary Shares (2,175 underlying) - Exercise/Conversion
Ordinary Shares
2022-08-17$0.00/sh+649$0→ 724 total - Exercise/Conversion
Ordinary Shares
2022-08-18$0.00/sh+2,175$1→ 2,250 total - Sale
Ordinary Shares
2022-08-18$4.84/sh−2,175$10,531→ 75 total
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 - $4.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.18 - $4.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.